Back
Gilead Sciences 10K Form
Buy
60
GILD
Gilead Sciences
Last Price:
78.80
Seasonality Move:
2.95%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2021-02-25 | 10K | GILD/Gilead Sciences Annual |
2020-11-04 | 10Q | GILD/Gilead Sciences Quarterly |
2020-08-06 | 10Q | GILD/Gilead Sciences Quarterly |
2020-05-06 | 10Q | GILD/Gilead Sciences Quarterly |
2020-02-25 | 10K | GILD/Gilead Sciences Annual |
2019-11-05 | 10Q | GILD/Gilead Sciences Quarterly |
Receive GILD News And Ratings
See the #1 stock for the next 7 days that we like better than GILD
GILD Financial Statistics
Sales & Book Value
Annual Sales: | $27.28B |
---|---|
Cash Flow: | $2.39B |
Price / Cash Flow: | 11.76 |
Annual Sales: | $17.03 |
Price / Book: | 4.57 |
Profitability
EPS (TTM): | 3.65000 |
---|---|
Net Income (TTM): | $4.59B |
Gross Margin: | $21.62B |
Return on Equity: | 22.17% |
Return on Assets: | 7.18% |
Gilead Sciences Earnings Forecast
Key Gilead Sciences Financial Ratios
- The Gross Profit Margin over the past 32 years for GILD is 79.26%.
- The Selling, General & Administrative Expenses for GILD have been equal to 20.79% of Gross Profit Margin.
- The Research & Development expenses have been 18.24% of Revenue.
- The Interest Expense is 20.36% of Operating Income.
- The Net Earning history of GILD is 16.83% of Total Revenues.
- Per Share Earnings over the last 32 years have been positive in 18 years.
Gilead Sciences Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Drug Manufacturers - General |
Sector: | Healthcare |
Current Symbol: | GILD |
CUSIP: | 375558 |
Website: | gilead.com |
Debt
Debt-to-Equity Ratio: | 1.19 |
---|---|
Current Ratio: | 1.29 |
Quick Ratio: | 0.99 |
Price-to-Earnings
Trailing P/E Ratio: | 21.36 |
---|---|
Forward P/E Ratio: | 10.72 |
GILD Technical Analysis vs Fundamental Analysis
Buy
60
Gilead Sciences (GILD)
is a Buy
Is Gilead Sciences a Buy or a Sell?
-
Gilead Sciences stock is rated a Buy
The current Gilead Sciences [GILD] share price is $77.76. The Score for GILD is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.